114 related articles for article (PubMed ID: 22335485)
1. An update on targeting Hippo-YAP signaling in liver cancer.
Liu AM; Xu Z; Luk JM
Expert Opin Ther Targets; 2012 Mar; 16(3):243-7. PubMed ID: 22335485
[TBL] [Abstract][Full Text] [Related]
2. Hippo signaling in oval cells and hepatocarcinogenesis.
Zheng T; Wang J; Jiang H; Liu L
Cancer Lett; 2011 Mar; 302(2):91-9. PubMed ID: 21247686
[TBL] [Abstract][Full Text] [Related]
3. Hippo signaling pathway in companion animal diseases, an under investigated signaling cascade.
Budel SJ; Penning MM; Penning LC
Vet Q; 2021 Dec; 41(1):172-180. PubMed ID: 33945400
[TBL] [Abstract][Full Text] [Related]
4. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides.
Zhou Z; Hu T; Xu Z; Lin Z; Zhang Z; Feng T; Zhu L; Rong Y; Shen H; Luk JM; Zhang X; Qin N
FASEB J; 2015 Feb; 29(2):724-32. PubMed ID: 25384421
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapy of hepatocellular cancer.
Wysocki PJ
Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
[TBL] [Abstract][Full Text] [Related]
6. Herding Hippos: regulating growth in flies and man.
Badouel C; Garg A; McNeill H
Curr Opin Cell Biol; 2009 Dec; 21(6):837-43. PubMed ID: 19846288
[TBL] [Abstract][Full Text] [Related]
7. Hippo signaling: a hub of growth control, tumor suppression and pluripotency maintenance.
Yin M; Zhang L
J Genet Genomics; 2011 Oct; 38(10):471-81. PubMed ID: 22035868
[TBL] [Abstract][Full Text] [Related]
8. Targeting high Aurora kinases expression as an innovative therapy for hepatocellular carcinoma.
Liu F; Wang G; Wang X; Che Z; Dong W; Guo X; Wang Z; Chen P; Hou D; Zhang Q; Zhang W; Pan Y; Yang D; Liu H
Oncotarget; 2017 Apr; 8(17):27953-27965. PubMed ID: 28427193
[TBL] [Abstract][Full Text] [Related]
9. [Role of Hippo-YAP/TAZ signaling pathway in mechanotransduction.].
Ishihara E; Nishina H
Clin Calcium; 2016; 26(12):1751-1756. PubMed ID: 27885187
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway.
Zhang J; Smolen GA; Haber DA
Cancer Res; 2008 Apr; 68(8):2789-94. PubMed ID: 18413746
[TBL] [Abstract][Full Text] [Related]
11. YAP and WWTR1: New targets for skin cancer treatment.
Andl T; Zhou L; Yang K; Kadekaro AL; Zhang Y
Cancer Lett; 2017 Jun; 396():30-41. PubMed ID: 28279717
[TBL] [Abstract][Full Text] [Related]
12. Neuregulin 1-activated ERBB4 as a "dedicated" receptor for the Hippo-YAP pathway.
Sudol M
Sci Signal; 2014 Dec; 7(355):pe29. PubMed ID: 25492964
[TBL] [Abstract][Full Text] [Related]
13. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
Bao ST; Gui SQ; Lin MS
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346
[TBL] [Abstract][Full Text] [Related]
14. A breakdown of the Hippo pathway in gastric cancer.
Xu ZP; Zhu JS; Zhang Q; Wang XY
Hepatogastroenterology; 2011; 58(110-111):1611-7. PubMed ID: 21940329
[TBL] [Abstract][Full Text] [Related]
15. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
Pang RW; Poon RT
Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
[TBL] [Abstract][Full Text] [Related]
16. ShRNA-targeted MAP4K4 inhibits hepatocellular carcinoma growth.
Liu AW; Cai J; Zhao XL; Jiang TH; He TF; Fu HQ; Zhu MH; Zhang SH
Clin Cancer Res; 2011 Feb; 17(4):710-20. PubMed ID: 21196414
[TBL] [Abstract][Full Text] [Related]
17. MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer.
Li L; Wang J; Zhang Y; Zhang Y; Ma L; Weng W; Qiao Y; Xiao W; Wang H; Yu W; Pan Q; He Y; Sun F
FEBS Lett; 2013 Dec; 587(24):3921-7. PubMed ID: 24211253
[TBL] [Abstract][Full Text] [Related]
18. The evolutionary history of YAP and the hippo/YAP pathway.
Hilman D; Gat U
Mol Biol Evol; 2011 Aug; 28(8):2403-17. PubMed ID: 21415026
[TBL] [Abstract][Full Text] [Related]
19. New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system.
Berasain C; Castillo J; Prieto J; Avila MA
Liver Int; 2007 Mar; 27(2):174-85. PubMed ID: 17311611
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Hippo signaling inhibits development of hepatocellular carcinoma.
Liu Y; Wang X; Yang Y
Clin Mol Hepatol; 2020 Oct; 26(4):742-750. PubMed ID: 32981290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
